SCFAs were reported to stimulate mitochondrial fatty acid oxidation by activating the UCP2-AMPK-ACC pathway, to prevent and reverse HFD-induced obesity and insulin resistance [56]. The gene discussed is UCP2; the disease is obesity due to melanocortin 4 receptor deficiency.